213 related articles for article (PubMed ID: 1818384)
1. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
[TBL] [Abstract][Full Text] [Related]
2. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
[TBL] [Abstract][Full Text] [Related]
3. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
4. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
5. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
Kanra G; Ceyhan M
Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
Rogers S; Sanders RC; Alpers MP
J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
[TBL] [Abstract][Full Text] [Related]
9. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
[TBL] [Abstract][Full Text] [Related]
10. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
[TBL] [Abstract][Full Text] [Related]
11. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
[TBL] [Abstract][Full Text] [Related]
12. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
13. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
[TBL] [Abstract][Full Text] [Related]
14. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Cite Soleil/JHU Project Team.
Job JS; Halsey NA; Boulos R; Holt E; Farrell D; Albrecht P; Brutus JR; Adrien M; Andre J; Chan E
Pediatr Infect Dis J; 1991 Apr; 10(4):303-11. PubMed ID: 2062626
[TBL] [Abstract][Full Text] [Related]
15. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.
Sabin AB; Flores Arechiga A; Fernández de Castro J; Albrecht P; Sever JL; Shekarchi I
JAMA; 1984 May; 251(18):2363-71. PubMed ID: 6368888
[TBL] [Abstract][Full Text] [Related]
16. Edmonston-Zagreb strain of measles vaccine: epidemiologic evaluation in Yugoslavia.
Ikić DM
Rev Infect Dis; 1983; 5(3):558-63. PubMed ID: 6879014
[TBL] [Abstract][Full Text] [Related]
17. Immunization of young infants with Edmonston-Zagreb measles vaccine.
Markowitz LE; Bernier RH
Pediatr Infect Dis J; 1987 Sep; 6(9):809-12. PubMed ID: 3313247
[TBL] [Abstract][Full Text] [Related]
18. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
[TBL] [Abstract][Full Text] [Related]
19. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
Cutts FT; Monteiro O; Tabard P; Cliff J
Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
[TBL] [Abstract][Full Text] [Related]
20. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
